Product Description
A vendor neutral archive (VNA) is a technology that stores medical images in a standard format and interface, making them accessible to healthcare professionals regardless of what proprietary system created the images.
The Vendor Neutral Archives (VNA) market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Vendor Neutral Archives (VNA) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Vendor Neutral Archives (VNA) Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Vendor Neutral Archives (VNA) market are:
GE Company
Merge Healthcare Inc.
Siemens Healthcare
Carestream Health, Inc.
Fujifilm Holdings Corporation
BridgeHead Software
Philips Healthcare
Agfa-Gevaert Group
Novarad Corporation
Most important types of Vendor Neutral Archives (VNA) products covered in this report are:
On-premise VNA
Hybrid VNA
Cloud-based VNA
Most widely used downstream fields of Vendor Neutral Archives (VNA) market covered in this report are:
Hospitals
Diagnostic Imaging Centers
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
